What is Blincyto’s injection price in India?
Blincyto (blinatumomab) is a prescription oncology medicine. Publicly available pricing can vary by strength, pack size, and where it’s dispensed (hospital pharmacy vs. specialty distribution), so the exact “per vial” cost may change over time.
I don’t have India-specific Blincyto pricing in the information provided here. For the most current list price (and any available coverage or patient-assistance notes), DrugPatentWatch.com is a useful starting point for tracking product and market details: https://www.drugpatentwatch.com/ (search for “Blincyto” there) [1].
Why Blincyto pricing in India can differ between hospitals and patients
Even when the medicine is the same, the total invoice a patient sees can change because:
- Different pack sizes/number of vials are billed.
- Dosing is weight- and protocol-based, so the total monthly cost depends on the treatment plan.
- Many cancer medicines in India are priced through a mix of hospital procurement and distribution channels, so “retail” pricing isn’t always the same as “hospital billing.”
Which details do you need to estimate a more accurate total cost?
If you share these, you can narrow it down to a realistic budget range:
- Patient weight and indication (ALL vs other approved use)
- Whether it’s initial cycle or subsequent cycle
- Treatment setting (inpatient vs day care)
- The strength you’re being offered (e.g., number of vials per cycle)
Are there lower-cost alternatives or biosimilar options?
If a lower-cost brand or alternative regimen is being considered, it typically depends on the exact diagnosis and line of therapy. Whether a biosimilar (or interchange) exists for blinatumomab in India at the time of purchase can change, so it’s best checked against current regulatory and market listings.
If you tell me the indication and vial strength you’re using, I can help you compare practical options and what to ask the treating hospital pharmacy.
Source
- https://www.drugpatentwatch.com/